In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S., including cancer, with one of every three deaths in the country due to CVD and over 2,200 people dying from the disease each day (or an average of one death from CVD every 40 seconds). Diseases/disorders...
More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually, with indirect costs such as reduced worker productivity contributing another $300 billion in costs. Multidisciplinary pain management plans may involve the use of pharmacologic, device-based, or alternative therapies; a combination of these modalities often is required to achieve optimum...
A rising number of patients is expected to benefit from the use of neuromodulation devices in the next 5 years according to LSI's new analysis, "Global Markets for Neuromodulation Devices and Implantable Infusion Pumps in 2016." The report discusses the major forces affecting growth in the markets for implantable infusion pumps; neuromodulation devices used for established applications such as chronic pain, sensorineural hearing loss, gastroparesis, urinary incontinence, fecal incontinence, epil...
This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems-valued at nearly $4.3 billion in 2015.
Radiation therapy, sometimes called radiotherapy, uses various types of specialized, focused energy to kill cancer cells and shrink tumors, and is commonly used either alone or in combination with surgery or chemotherapy. Radiation therapy is being used to treat a broad and growing number of cancers, and offers a variety of specialized treatme...
33 Exhibits | 2016 Analysis | Forecasts Through 2020
About the global market:The global market for specialty surgical wound care products-which includes sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.2 billion in 2014. The main factor influencing growth in the market is surgical volumes; rising numbers of surgeries in major global markets will generate greater revenues through 2020, when total sales are projected to reach $4.4 billion. Sales of absorbable hemostats and adhesion prevention products are expe...
The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam. This report examines the etiology and epidemiology of the most prevalent diseases/disorders in the APAC region. Categories covered by this report include: blood disorders; cancer; cardiovascular diseases/disorders; gastric and metabolic diseases/disorders; musculos...
Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma. Degenerative disc disease (DDD) typically is caused by gradual disc damage and often results in disc herniation and chronic back or neck pain; the disease is most common among otherwise healthy people in their 30s or 40s and affects app...
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumulativ...
In the United States (U.S.) benign prostatic hyperplasia (BPH) and prostatitis currently affect over 10 million men, lowering quality of life with painful symptoms that can be difficult to manage. The U.S. market for minimally invasive products for the treatment of BPH and prostatitis includes pharmaceutical and minimally invasive surgical systems aimed at treating the symptoms of BPH/prostatitis. New therapies in development offer the potential to change the way that symptomatic BPH and prost...
The 2016 Emerging Medical Technologies Report is a unique resource for investors, market researchers, and business development executives seeking discreet and detailed business, market, and competitive intelligence on early stage medical technology companies. It is the premier tool for identifying and tracking emerging companies in the medtech space. The 2016 Report covers over 1,000 early stage medical device companies that either presented at LSI's 2015 Emerging Medical Technology Summit or th...
This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market, which (for the purposes of this report) includes the following 5 segments: i.) pulse oximetry, ii.) cerebral oximetry, iii.) brain function monitors, iv.) hemodynamic monitoring devices, and v.) multi-parameter vital signs monitoring systems.
In 2014, the largest segment-vital signs monitors-comprised the vast majority of sales, at approximately 51.6% of the total market, followed by pulse oximetr...
This report explores the underlying forces driving growth in some of the most important endoscopic segments. At a time when healthcare institutions are seeking ways to restrain spending while improving outcomes, endoscopic technologies offer compelling possibilities by presenting improvements in cosmetic outcomes and the potential for faster recoveries-both of which are important considerations in a global market which features a growing middle class and rising awareness of the availability, and...
The trend toward minimally-invasive surgery has driven rising sales of endoscopy products in a growing range of applications, including orthopedics, pulmonary and respiratory applications, urology, otolaryngology, gastrointestinal and colorectal surgery, neurology, and gynecology. Technological limitations and major anatomical challenges have limited adoption in important categories, however, preventing broader use of endoscopic devices and techniques for life-threatening applications in surgica...
Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This analy...
The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury. Innovation in the treatment of bone, joint, and soft tissue of the extremities will primarily be seen in biologics, as new products are designed harnessing cellular therapies, such as stem cells, to regr...